Paradoxical Role of IL-17 in Progression of Diabetic Nephropathy.
作者信息
Galvan Daniel L, Danesh Farhad R
机构信息
Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and.
Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Pharmacology, Baylor College of Medicine, Houston, Texas
出版信息
J Am Soc Nephrol. 2016 Mar;27(3):657-8. doi: 10.1681/ASN.2015070813. Epub 2015 Sep 2.
Abstract
摘要
相似文献
1
Paradoxical Role of IL-17 in Progression of Diabetic Nephropathy.
J Am Soc Nephrol. 2016 Mar;27(3):657-8. doi: 10.1681/ASN.2015070813. Epub 2015 Sep 2.
2
Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
J Am Soc Nephrol. 2016 Mar;27(3):745-65. doi: 10.1681/ASN.2014111136. Epub 2015 Sep 2.
3
Prevention and treatment of diabetic nephropathy.
Adv Nephrol Necker Hosp. 1979;8:63-86.
4
[Early diagnosis is essential to inhibit the progression of diabetic nephropathy].
Nihon Jinzo Gakkai Shi. 2007;49(5):481-4.
5
[Inhibitory effect of elastase on diabetic nephropathy in experimental diabetic mice].
Hokkaido Igaku Zasshi. 2002 Sep;77(5):429-38.
6
7
Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation.
Transplant Proc. 1987 Feb;19(1 Pt 3):2290-3.
8
Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.
Exp Diabetes Res. 2012;2012:209567. doi: 10.1155/2012/209567. Epub 2012 Sep 4.
9
The effect of bromhexine on experimentally induced diabetic nephropathy.
Br J Exp Pathol. 1983 Aug;64(4):462-5.
10
Glomerular lesions of diabetes mellitus: preventable and reversible.
Nephrol Dial Transplant. 1999 Jan;14(1):19-21. doi: 10.1093/ndt/14.1.19.
引用本文的文献
1
Associations Between Serum IL-17A, Renal Function and Diabetic Retinopathy in Type 2 Diabetes Mellitus: Evidence From a Chinese Han Population.
Endocrinol Diabetes Metab. 2025 Mar;8(2):e70033. doi: 10.1002/edm2.70033.
2
IL-17A Levels and Progression of Kidney Disease Following Hospitalization with and without Acute Kidney Injury.
Kidney360. 2024 Nov 1;5(11):1623-1632. doi: 10.34067/KID.0000000000000559. Epub 2024 Sep 4.
3
Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients.
Sci Rep. 2024 Feb 28;14(1):4866. doi: 10.1038/s41598-024-55425-7.
4
The Complex Network of Cytokines and Chemokines in Pediatric Patients with Long-Standing Type 1 Diabetes.
Int J Mol Sci. 2024 Jan 26;25(3):1565. doi: 10.3390/ijms25031565.
5
IL-17C neutralization protects the kidney against acute injury and chronic injury.
EBioMedicine. 2023 Jun;92:104607. doi: 10.1016/j.ebiom.2023.104607. Epub 2023 May 30.
6
A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation.
Appl Microbiol Biotechnol. 2023 Apr;107(7-8):2561-2576. doi: 10.1007/s00253-023-12431-5. Epub 2023 Feb 27.
7
Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control.
Biomed Res Int. 2021 Sep 13;2021:7297419. doi: 10.1155/2021/7297419. eCollection 2021.
8
Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
BMC Nephrol. 2021 Jul 2;22(1):245. doi: 10.1186/s12882-021-02447-2.
9
IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.
Mol Med. 2021 Mar 10;27(1):25. doi: 10.1186/s10020-021-00285-4.
10
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications.
Front Med (Lausanne). 2021 Jan 22;7:628289. doi: 10.3389/fmed.2020.628289. eCollection 2020.
本文引用的文献
1
Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
J Am Soc Nephrol. 2016 Mar;27(3):745-65. doi: 10.1681/ASN.2014111136. Epub 2015 Sep 2.
2
CD4 T cell differentiation in type 1 diabetes.
Clin Exp Immunol. 2016 Jan;183(1):16-29. doi: 10.1111/cei.12672. Epub 2015 Jul 28.
3
Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression.
Transl Res. 2015 Oct;166(4):375-83. doi: 10.1016/j.trsl.2015.04.013. Epub 2015 May 5.
4
Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension.
Hypertension. 2014 Mar;63(3):565-71. doi: 10.1161/HYPERTENSIONAHA.113.02620. Epub 2013 Dec 23.
5
High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression.
Cell Signal. 2014 Mar;26(3):528-39. doi: 10.1016/j.cellsig.2013.11.031. Epub 2013 Dec 2.
6
IL-17 family: cytokines, receptors and signaling.
Cytokine. 2013 Nov;64(2):477-85. doi: 10.1016/j.cyto.2013.07.022. Epub 2013 Sep 3.
7
Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse.
Diabetologia. 2013 Aug;56(8):1773-80. doi: 10.1007/s00125-013-2935-8. Epub 2013 May 23.
8
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11548-53. doi: 10.1073/pnas.1108924108. Epub 2011 Jun 27.
9
Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
J Immunol. 2011 Apr 1;186(7):4481-9. doi: 10.4049/jimmunol.1000148. Epub 2011 Feb 23.
10
IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.
J Immunol. 2010 Apr 15;184(8):4307-16. doi: 10.4049/jimmunol.0903614. Epub 2010 Mar 15.
Zotero 插件